Мониторинг безопасности зарегистрированных лекарственных средств у беременных: фармакогенетические аспекты
Е. А. Сокова · Safety and Risk of Pharmacotherapy · 2015
The purpose of this article is to describe and to examine the utility of new pharmacogenetic approaches in monitoring post-approval drug safety in pregnancy. Data on gene expression in pregnancy and metabolic variation may, in specific instances, help to predict adverse drug reactions in the mother-placenta-fetus complex and to identify individuals at a higher risk.
Cited by 0 works.